Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Goldsmith

Showing results (151-160 of 188) with videos related to

Pageof 19
Sort By:
International Urology and Nephrology|December 2, 2011
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney diseaseMehmet Kanbay, Myles Wolf, Yusuf Selcoki, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2006
Accelerating statistical research in drug safetyWarren Bilker, Victor Gogolak, David Goldsmith, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 18, 2014
Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countriesMona Al Rukhaimi, Ali Al Sahow, Yousef Boobes, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2017
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general populationAdrian Covic, Marc Vervloet, Ziad A Massy, et al.
Nature Reviews. Nephrology|November 3, 2011
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysisAlberto Ortiz, Ziad A Massy, Danilo Fliser, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 27, 2012
Serum vitamin D levels are independently associated with severity of coronary artery diseaseFatih Akin, Burak Ayça, Nuri Köse, et al.
International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysisIonut Nistor, Johan De Sutter, Christiane Drechsler, et al.
Internal and Emergency Medicine|May 19, 2011
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 studyLoreto Gesualdo, Gérard London, Matthew Turner, et al.
Journal of the American Society of Nephrology : JASN|February 6, 2015
Assessment and management of hypertension in transplant patientsMatthew R Weir, Ellen D Burgess, James E Cooper, et al.
Pageof 19

Showing results (151-160 of 188) with videos related to

Sort By:
Pageof 19
International Urology and Nephrology|December 2, 2011
Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney diseaseMehmet Kanbay, Myles Wolf, Yusuf Selcoki, et al.
Pharmacoepidemiology and Drug Safety|August 31, 2006
Accelerating statistical research in drug safetyWarren Bilker, Victor Gogolak, David Goldsmith, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|January 18, 2014
Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countriesMona Al Rukhaimi, Ali Al Sahow, Yousef Boobes, et al.
The Lancet. Diabetes & Endocrinology|October 21, 2017
Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general populationAdrian Covic, Marc Vervloet, Ziad A Massy, et al.
Nature Reviews. Nephrology|November 3, 2011
Clinical usefulness of novel prognostic biomarkers in patients on hemodialysisAlberto Ortiz, Ziad A Massy, Danilo Fliser, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|April 27, 2012
Serum vitamin D levels are independently associated with severity of coronary artery diseaseFatih Akin, Burak Ayça, Nuri Köse, et al.
International Urology and Nephrology|April 21, 2015
Risk-based individualisation of target haemoglobin in haemodialysis patients with renal anaemia in the post-TREAT era: theoretical attitudes versus actual practice patterns (MONITOR-CKD5 study)Loreto Gesualdo, Christian Combe, Adrian Covic, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2017
Effect of renin-angiotensin-aldosterone system blockade in adults with diabetes mellitus and advanced chronic kidney disease not on dialysis: a systematic review and meta-analysisIonut Nistor, Johan De Sutter, Christiane Drechsler, et al.
Internal and Emergency Medicine|May 19, 2011
A pharmacoepidemiological study of the multi-level determinants, predictors, and clinical outcomes of biosimilar epoetin alfa for renal anaemia in haemodialysis patients: background and methodology of the MONITOR-CKD5 studyLoreto Gesualdo, Gérard London, Matthew Turner, et al.
Journal of the American Society of Nephrology : JASN|February 6, 2015
Assessment and management of hypertension in transplant patientsMatthew R Weir, Ellen D Burgess, James E Cooper, et al.
Pageof 19